Revive Therapeutics grants 15,500,000 incentive stock options at $0.05 per share
Reuters2026/08/14 22:50- Revive Therapeutics authorized 15,500,000 incentive stock options for directors, officers, consultants, key team members.
- Options carry a $0.05 exercise price with a five-year term.
- Awards were issued under the company’s 10% rolling stock option plan.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The first major "exam" after the Cook era! Morgan Stanley: Apple's (AAPL.US) autumn launch event is the most important in ten years; the first foldable iPhone may spark a new wave of growth
Morgan Stanley analysts stated that Apple's upcoming "Surprise and Shine" autumn product launch event on September 9 may become the company's most important product release in nearly a decade.
10-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - Germany vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
